DOI: 10.1055/s-00000133

Gastroenterologie up2date

References

Faiss S, Pape UF, Böhmig M. et al.
Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors – The International Lanreotide and Interferon Alfa Study Group.

J Clin Oncol 2003;
21: 2689-2696

Download Bibliographical Data

Access:
Access: